Abdul Latif Jameel Fintech Fund
Abdul Latif Jameel is a diversified business of independent entities that include automotive distribution, auto parts manufacturing, financial services, renewable energy, environmental services, health, land and real estate development, logistics, electronics retailing and media services.
Established in 1945 Abdul Latif Jameel has dual headquarters in Jeddah, Saudi Arabia and Dubai, UAE, and currently has operations in 30 countries employing approximately 11,000 people from more than 40 nationalities.
Abdullah Fouad Holding
Abdulla Fouad Group (AFG) is a dynamic and diversified business group that continues to play a pivotal role in the Kingdom’s progress to this day.<br />
<br />
<br />
<br />
Beginning 65 years ago as a small service company established in Ras Tanura, AFG’s first mover advantage saw it expand into new industries, pioneering many products and services along the way. It is well known for excellence across its business units, serving the Oil & Gas, Energy, Healthcare, Information Technology, Consumer, and Construction sectors.<br />
<br />
<br />
<br />
Building on the groundwork laid by our late founder, Sheikh Abdulla Fouad, AFG has forged strong technical and commercial partnerships with renowned companies around the world, allowing it to provide its customers with world-class solutions.<br />
<br />
<br />
<br />
Headquartered in Dammam, AFG has regional offices in Riyadh, Jeddah, and several satellite offices across KSA & GCC, all dedicated to providing the highest possible customer service. AFG has long-standing relationships with a diverse client base across the region, including both public and private sector organizations.
Abénex
Abénex is a private equity firm based in Paris, France, founded in 1992. The firm has a team of 45 people, including 22 partners. Abénex is known for its expertise in capital development and transfer capital operations, and it also undertakes turnkey projects for investment in productive real estate assets.
Abénex primarily invests in sectors such as consumer goods, real estate, construction, and industrials. The firm focuses on companies in France and Belgium, with investment stages ranging from early revenue to buyouts. Abénex IV, a notable fund, closed with $427 million in 2010 and targets industries like restaurants, hotels, leisure, and manufacturing. Limited partners include HarbourVest Partners and the Alaska Permanent Fund.
Notable investments by Abénex include Ortec Groupe - construction and engineering, De Dietrich Process Systems - industrial supplies, Consolis - construction materials, APC - energy solutions, and Acteon Group - dental equipment.
Aberdare Ventures
Aberdare Ventures is a venture capital firm based in San Francisco, California, founded in 1999. The firm focuses on investments in the healthcare sector, aiming to support transformational companies that enhance healthcare efficiency and reduce costs. Aberdare Ventures operates as a Registered Investment Adviser and maintains a small team of professionals dedicated to identifying and nurturing innovative healthcare solutions.
The firm invests across various stages, including seed, early, and later stages, with a particular emphasis on healthcare-related industries such as medical devices, healthcare services, and biotechnology. Aberdare Ventures typically participates in venture rounds, with investments ranging from early-stage to later-stage VC. The firm manages several funds, including Aberdare Ventures Fund II, which has an AUM of $350 million.
Notable portfolio companies include Vir Biotechnology - drug discovery, Cricket Health - clinics/outpatient services, Indigo Ag - agriculture, Gravie - other insurance, and Vydence Medical - diagnostic equipment. These investments reflect Aberdare Ventures' commitment to advancing healthcare innovation through strategic capital deployment.
Aberdeen
Our ambition is to be the UK’s leading Wealth and Investments group.
At Aberdeen, we believe investing is about more than numbers – it’s about helping people shape their futures. Whether they're starting out, planning for retirement, advising others, or managing large portfolios, we partner with our customers and clients to ensure they have the tools and insight they need to navigate an ever-changing world.
Aberdeen – enabling our clients to be better investors.
ABG Alternative Investments
ABG Alternatives is a subsidiary of ABG Sundal Collier and a licensed manager of alternative investment funds.
Abies Ventures
Abies Ventures is a venture capital firm based in Tokyo, Japan, focusing on early-stage deep tech startups. The firm is led by Managing Partners Fuyuki Yamaguchi and Sota Nagano, with a team that includes investment managers and advisors. Abies Ventures distinguishes itself through its global network, collaborating with major corporations, accelerators, and research institutions to support startups in addressing significant global challenges.
The firm invests in a wide range of sectors, including deep tech and data science, with a particular emphasis on innovative technologies that can solve pressing issues. Abies Ventures typically invests in early-stage companies, providing them with the necessary resources to scale globally. The firm has not publicly disclosed its total assets under management or specific fund details.
Notable investments by Abies Ventures include A-Star Quantum - quantum computing solutions, Pixie Dust Technologies - sound wave technology, Solaris - solar energy solutions, Qubitcore - quantum computing hardware, and Aufense - AI-driven security solutions. These investments highlight the firm's commitment to supporting groundbreaking technologies that have the potential to make a significant impact.
Abingworth
Abingworth is a life sciences investor based in London, New York, and San Francisco, founded in the 1980s. With a long history in biotech investing, the firm has expanded transatlantically, supporting over 200 companies with their team of 28 professionals. Known for their experience in navigating startups through various challenges, Abingworth takes pride in their strategic support to portfolio companies through unique approaches such as Venture Investments in Public Equities (VIPEs) and Clinical Co-Development.
Abingworth invests in life sciences and healthcare sectors, focusing on biotechnology and pharmaceuticals. They participate in seed, early, and development-stage funding, with investments primarily in North America and Europe. The firm manages multiple funds including Abingworth Bioventures funds and Clinical Co-Development funds, with recent fundraises totaling over $1 billion. Abingworth's presence in key biotech hubs enables direct interaction with talented entrepreneurs.
Noteworthy portfolio companies include Prism - precision medicine, F2G - antifungal treatments, GammaDelta - oncology therapies, and Inflazome - inflammasome inhibitors. Abingworth has a record of taking companies through IPOs and strategic transactions, utilizing their deep life sciences expertise.
Able Partners
Able Partners is a venture capital firm based in New York, founded in 2016. The firm is led by a small team of professionals who focus on investing in early-stage consumer brands that promote health and wellness. They are known for supporting entrepreneurs who are building visionary brands aimed at improving the daily lives of consumers by making them healthier and happier.
Able Partners invests primarily in sectors such as healthcare, consumer wellbeing, and the care economy. They typically invest in Seed and Series A stages, with check sizes ranging from $500K to $3M. The firm focuses on the USA market and has a portfolio of 64 companies, with 42 successful exits. Notable funds include their initial fund launched in 2016.
Some of their notable portfolio companies include Alma - mental health services, Compass Pathways - mental health care, Blueland - eco-friendly cleaning products, Midi - menopause care, and Function Health - personalized health services. These investments reflect their commitment to narrowing the wellness gap and supporting brands that make a positive impact on society.
ABN AMRO Participaties BV
ABN AMRO Participaties BV is a private equity investor based in the Netherlands, operating as a subsidiary of ABN AMRO Bank N.V. Founded to focus on middle-market investments in a range of industries, they leverage the financial expertise and resources of their parent company to identify promising opportunities. The firm distinguishes itself through a strategic approach to sustainability and long-term value creation, aligned with ABN AMRO’s wider commitment to impact-driven investing.
Their investment focus spans various industries, including technology, healthcare, industrials, and energy. ABN AMRO Participaties typically invests in buyout and growth equity opportunities, primarily in North America and Europe. The company aims to create synergistic partnerships that can drive operational improvements and strategic growth in portfolio companies.
Notable investments include companies involved in technology and industrial services, supporting these businesses to scale and enhance their market positions. They maintain a strong track record of successful exits and continue to actively manage and grow their investment portfolio in alignment with their strategic goals.
